Pain And Therapy

Journal Title：Pain And Therapy

Pain and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of pain therapies and pain-related devices. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to, acute pain, cancer pain, chronic pain, headache and migraine, neuropathic pain, opioids, palliative care and pain ethics, peri- and post-operative pain as well as rheumatic pain and fibromyalgia.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, trial protocols, short communications such as commentaries and editorials, and letters. The journal is read by a global audience and receives submissions from around the world. Pain and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

《疼痛與治療》是一本國際性、開放獲取、同行評審、快速出版的期刊，致力于發表高質量的臨床（所有階段）、觀察性、真實世界和健康結果研究，研究內容涉及疼痛療法和疼痛相關設備的發現、開發和使用。還鼓勵發表與診斷、藥物經濟學、公共衛生、生活質量以及患者護理、管理和教育相關的研究。

重點領域包括但不限于急性疼痛、癌痛、慢性疼痛、頭痛和偏頭痛、神經性疼痛、阿片類藥物、姑息治療和疼痛倫理、圍手術期和術后疼痛以及風濕性疼痛和纖維肌痛。

該期刊受到廣大制藥和醫療保健專業人士的關注，發表原創研究、綜述、病例報告、試驗方案、簡短通訊（如評論和社論）和信件。該期刊的讀者遍布全球，并收到來自世界各地的投稿。 《疼痛與治療》將考慮所有科學合理的研究，無論是正面數據、確認數據還是負面數據。無論投稿涉及國際和/或特定國家/地區的受眾，我們都歡迎投稿，當研究人員試圖針對更具體的患者群體時，這一點至關重要。這種包容性方法使該期刊能夠協助傳播所有科學和倫理合理的研究。

Pain And Therapy創刊于2012年，由Springer Healthcare出版商出版，收稿方向涵蓋CLINICAL NEUROLOGY全領域，此刊是該細分領域中屬于非常不錯的SCI期刊，在行業細分領域中學術影響力較大，專業度認可很高，所以對原創文章要求創新性較高，如果您的文章質量很高，可以嘗試。平均審稿速度 6 Weeks ，影響因子指數4.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。